Evidence map›Paper›PMID 38053540›Full record

ArticleFrontiers in psychiatry2023

Case report: Olanzapine-associated water retention, high blood pressure, and subsequent preterm preeclampsia.

Julia Izsak, Dimitra Falari, Pia Arnbert, Daniel Pouragheli, Jenny M Kindblom, Daina Lasaitiene

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Julia IzsakDepartment of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Dimitra FalariDepartment of Psychiatry, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pia ArnbertDepartment of Psychiatry, Sahlgrenska University Hospital, Gothenburg, Sweden.
Daniel PouragheliDepartment of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Jenny M KindblomDepartment of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Daina LasaitieneDepartment of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Sahlgrenska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Olanzapine is one of the most frequently used antipsychotic medications during pregnancy, but information about its safety and adverse effects profile during pregnancy is scarce. We herein describe a case of a pregnant woman with several psychiatric disorders who developed water retention, hypertension, and subsequent preterm preeclampsia 3 weeks after initiation of treatment with olanzapine. To the best of our knowledge, this is the first case of olanzapine-associated preeclampsia described in literature.

Indexed as

hypertensionolanzapinepreeclampsiapregnancywater retention

Identifiers

PMID38053540
PMCPMC10694189
OpenAlexW4388813766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.